Experiments using a specific antagonist or knockdown of the NTSR1 using short interfering RNA suggest that NTSR1 mediates the effects of neurotensin on cancer cells, although NTSR3/sortilin, which is often coexpressed in cancer cells, may modulate NTSR1 signalling [14,16]. Here, SORT1 is linked to cancer.